MT200605
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MT200605, covering 2024-11-21 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke [Phase 2]